View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Service Listings   |   Industry News   |   Events
April 12, 2016
learn more
Newsletter Sponsor
   Pfanstiehl is expanding its HPAPI CDMO offerings
with immediate capacity availability and a wider array of process chemistry expertise
Pfanstiehl has invested in capacity, state of the art equipment, and people who have a passion for developing solutions for clients with complex chemistry challenges. Pfanstiehl’s ideal partner is one who is looking for a CDMO partner that will walk lockstep with them through their drug development lifecycle. We work with firms who really value personalized attention and excellence in execution. We are selective with the programs we take on, so that each one has every opportunity for success.

more info

» Industry News
 
more news
» Featured Articles
Implementation and Long-Term Maintenance of QbD Products in a Virtual Supply Chain
Implementation and Long-Term Maintenance of QbD Products in a Virtual Supply Chain
Quality-by-Design (QbD) is now a well-established and commonly employed approach to the development and commercialization of products in the pharmaceutical industry. According to a 2012 survey ... read more »
The Perils and Promise of Strategic Partnering with CROs
The Perils and Promise of Strategic Partnering with CROs
Strategic partnerships have long been a major feature of the pharmaceutical industry. In-licensing, out-licensing, joint research, and codevelopment arrangements between and among bio-pharmaceutical... read more »
more articles
 
» Featured Video
learn more
  Webinar: Using ultrasensitive immunoassays to search for mutant HTT protein in Huntington’s disease patient CSF
Webinar: Using ultrasensitive immunoassays to search for mutant HTT protein in Huntington’s disease patient CSF
Reducing the amount of mutant HTT protein is a key therapeutic strategy for Huntington's disease. In this webinar, learn about a new sensitive and selective assay that measures polyglutamine-expanded ... read more »
learn more
  INC Research: Committed to Site and Patient Access
INC Research: Committed to Site and Patient Access
Clare Grace, Ph.D., Vice President of Site and Patient Access at INC Research, talks with Mike Auerbach of Pharmaceutical Outsourcing at DIA 2015 about building relationships with clinical trial sites... read more »

more videos
 
» Events
 
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA